SPARC

SUN PHARMA ADVANCED RESEARCH COMPANY

Mid Cap BSE: 532872 NSE: SPARC
₹251.85
2.1 (0.84%)
As on 06 December, 2022 | 23:03

Sun Pharma Advanced Research Company Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in SUN PHARMA ADVANCED RESEARCH COMPANY

Start SIP

Sun Pharma Advanced Research Company Share Price

Sun Pharma Advanced Research Company Share Returns

  • Over 1 Month -3.41%
  • Over 3 Month 10.15%
  • Over 6 Month 16.57%
  • Over 1 Year 2.65%

Sun Pharma Advanced Research Company Key Statistics

P/E Ratio -28.8
PEG Ratio -21.6
Market Cap Cr 6,847
Price to Book Ratio 219.3
EPS -7.7
Dividend 0
Relative Strength Index 55.14
Money Flow Index 60.3
MACD Signal 3.44
Average True Range 8.33

Sun Pharma Advanced Research Company Investment Rating

  • Master Rating:
  • Sun Pharma Advd.Resh. has an operating revenue of Rs. 147.39 Cr. on a trailing 12-month basis. An annual revenue de-growth of -44% needs improvement, Pre-tax margin of -148% needs improvement, ROE of -651% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 5% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It has recently broken out of a base in its weekly chart and is trading around 2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 17 which is a POOR score indicating inconsistency in earnings, a RS Rating of 48 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 158 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sun Pharma Advanced Research Company Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 32282562282228
Operating Expenses Qtr Cr 941079273837678
Operating Profit Qtr Cr -63-78-67-11-55-54-50
Depreciation Qtr Cr 3333333
Interest Qtr Cr 3222354
Tax Qtr Cr 0000000
Net Profit Qtr Cr -68-82-71-16-55-61-57

Sun Pharma Advanced Research Company Technicals

EMA & SMA

Current Price
251.85
2.1 (0.84%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 248.32
  • 50 Day
  • 241.49
  • 100 Day
  • 237.23
  • 200 Day
  • 239.57
  • 20 Day
  • 248.02
  • 50 Day
  • 238.09
  • 100 Day
  • 231.5
  • 200 Day
  • 239.72

Sun Pharma Advanced Research Company Resistance and Support

PIVOT
₹251.04
Resistance
First Resistance 254.07
Second Resistance 258.39
Third Resistance 261.42
RSI 55.14
MFI 60.3
MACD Single Line 3.44
MACD 3.28
Support
First Resistance 246.72
Second Resistance 243.69
Third Resistance 239.37

Sun Pharma Advanced Research Company Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 219,961 8,105,563 36.85
Week 311,326 10,491,686 33.7
1 Month 342,520 9,950,194 29.05
6 Month 541,275 14,186,810 26.21

Sun Pharma Advanced Research Company Result Highlights

Sun Pharma Advanced Research Company Synopsis

NSE-Medical-Biomed/Biotech

Sun Pharma Advanced is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 137.25 Cr. and Equity Capital is Rs. 27.19 Cr. for the Year ended 31/03/2022. Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837.
Market Cap 6,847
Sales 147
Shares in Float 8.43
No of funds 68
Yield
Book Value 219.13
U/D Vol ratio 2
LTDebt / Equity
Alpha -0.01
Beta 1.39

Sun Pharma Advanced Research Company

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 69.09%69.09%69.09%
Mutual Funds 0.24%0.24%0.24%
Foreign Portfolio Investors 2.38%2.4%2.38%
Financial Institutions/ Banks
Individual Investors 15.7%16.46%14.73%
Others 12.59%11.81%13.56%

Sun Pharma Advanced Research Company Management

Name Designation
Mr. Dilip S Shanghvi Chairman
Dr. T Rajamannar Non Executive Director
Dr. Robert J Spiegel Non Executive Director
Mr. Sudhir V Valia Non Executive Director
Ms. Bhavna Doshi Independent Director
Dr. Ferzaan Engineer Independent Director

Sun Pharma Advanced Research Company Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sun Pharma Advanced Research Company Corporate Action

Date Purpose Remarks
2022-11-07 Quarterly Results
2022-08-08 Quarterly Results & Others Inter alia, to consider and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.
2022-05-17 Audited Results
2022-02-04 Quarterly Results
2021-11-01 Quarterly Results

Sun Pharma Advanced Research Company MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 2355
Motilal Oswal Nifty 500 Fund Regular Growth 368
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 367
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 309
SBI Nifty Smallcap 250 Index Fund Regular Growth 103

Sun Pharma Advanced Research Company FAQs

What is Share Price of Sun Pharma Advanced Research Company ?

Sun Pharma Advanced Research Company share price is ₹251 As on 06 December, 2022 | 22:49

What is the Market Cap of Sun Pharma Advanced Research Company ?

The Market Cap of Sun Pharma Advanced Research Company is ₹6847.3 Cr As on 06 December, 2022 | 22:49

What is the P/E ratio of Sun Pharma Advanced Research Company ?

The P/E ratio of Sun Pharma Advanced Research Company is -28.8 As on 06 December, 2022 | 22:49

What is the PB ratio of Sun Pharma Advanced Research Company ?

The PB ratio of Sun Pharma Advanced Research Company is 219.3 As on 06 December, 2022 | 22:49

Q2FY23